Tecentriq 1200 mg/20 mL solution for intravenous infusion Images

Generic Name: atezolizumab

This medication has been identified as Tecentriq 1200 mg/20 mL solution for intravenous infusion. It is supplied by Genentech, Inc.

Tecentriq is used in the treatment of Hepatocellular Carcinoma; Small Cell Lung Cancer; Non Small Cell Lung Cancer; Alveolar Soft Part Sarcoma; Melanoma and belongs to the drug class anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors). Tecentriq 1200 mg/20 mL solution for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Tecentriq

Generic Name

atezolizumab

Strength

1200 mg/20 mL solution for intravenous infusion

Availability

Prescription only

Drug Class

Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

CSA Schedule

Not a controlled drug

Labeler / Supplier

Genentech, Inc.

National Drug Code (NDC)

50242-0917

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer